PubMed:8829135 / 277-502 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T3","span":{"begin":0,"end":225},"obj":"Sentence"}],"text":"Given that apomorphine inhibits passive avoidance retention when given during training or in a defined 10-12h post-training period, we evaluated the ability of nefiracetam to attenuate amnesia induced by dopaminergic agonism."}

{"project":"LitCoin-entities","denotations":[{"id":"183","span":{"begin":11,"end":22},"obj":"ChemicalEntity"},{"id":"184","span":{"begin":160,"end":171},"obj":"ChemicalEntity"},{"id":"185","span":{"begin":185,"end":192},"obj":"DiseaseOrPhenotypicFeature"},{"id":"186","span":{"begin":204,"end":224},"obj":"ChemicalEntity"}],"attributes":[{"id":"A9","pred":"db_id","subj":"183","obj":"MESH:D001058"},{"id":"A10","pred":"db_id","subj":"184","obj":"MESH:C058876"},{"id":"A11","pred":"db_id","subj":"185","obj":"MESH:D000647"},{"id":"A12","pred":"db_id","subj":"186","obj":"MESH:D018491"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Given that apomorphine inhibits passive avoidance retention when given during training or in a defined 10-12h post-training period, we evaluated the ability of nefiracetam to attenuate amnesia induced by dopaminergic agonism."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T6","span":{"begin":78,"end":94},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":110,"end":114},"obj":"GeneOrGeneProduct"},{"id":"T8","span":{"begin":124,"end":130},"obj":"GeneOrGeneProduct"},{"id":"T9","span":{"begin":175,"end":184},"obj":"GeneOrGeneProduct"},{"id":"T10","span":{"begin":193,"end":200},"obj":"GeneOrGeneProduct"}],"text":"Given that apomorphine inhibits passive avoidance retention when given during training or in a defined 10-12h post-training period, we evaluated the ability of nefiracetam to attenuate amnesia induced by dopaminergic agonism."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T3","span":{"begin":110,"end":114},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":124,"end":130},"obj":"GeneOrGeneProduct"}],"text":"Given that apomorphine inhibits passive avoidance retention when given during training or in a defined 10-12h post-training period, we evaluated the ability of nefiracetam to attenuate amnesia induced by dopaminergic agonism."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T3","span":{"begin":185,"end":192},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"originalLabel","subj":"T3","obj":"D000647"}],"text":"Given that apomorphine inhibits passive avoidance retention when given during training or in a defined 10-12h post-training period, we evaluated the ability of nefiracetam to attenuate amnesia induced by dopaminergic agonism."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T1","span":{"begin":124,"end":130},"obj":"GeneOrGeneProduct"}],"text":"Given that apomorphine inhibits passive avoidance retention when given during training or in a defined 10-12h post-training period, we evaluated the ability of nefiracetam to attenuate amnesia induced by dopaminergic agonism."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T4","span":{"begin":185,"end":192},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"0001152"}],"text":"Given that apomorphine inhibits passive avoidance retention when given during training or in a defined 10-12h post-training period, we evaluated the ability of nefiracetam to attenuate amnesia induced by dopaminergic agonism."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T4","span":{"begin":185,"end":192},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"ID:","subj":"T4","obj":"D000647"}],"text":"Given that apomorphine inhibits passive avoidance retention when given during training or in a defined 10-12h post-training period, we evaluated the ability of nefiracetam to attenuate amnesia induced by dopaminergic agonism."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T4","span":{"begin":185,"end":192},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"#label","subj":"T4","obj":"D000647"}],"text":"Given that apomorphine inhibits passive avoidance retention when given during training or in a defined 10-12h post-training period, we evaluated the ability of nefiracetam to attenuate amnesia induced by dopaminergic agonism."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T12","span":{"begin":11,"end":22},"obj":"ChemicalEntity"},{"id":"T14","span":{"begin":160,"end":171},"obj":"ChemicalEntity"},{"id":"T16","span":{"begin":204,"end":224},"obj":"ChemicalEntity"}],"attributes":[{"id":"A12","pred":"ID:","subj":"T12","obj":"D001058"},{"id":"A13","pred":"ID:","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_48538"},{"id":"A14","pred":"ID:","subj":"T14","obj":"C058876"},{"id":"A15","pred":"ID:","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_135004"},{"id":"A16","pred":"ID:","subj":"T16","obj":"ChemicalEntity"}],"text":"Given that apomorphine inhibits passive avoidance retention when given during training or in a defined 10-12h post-training period, we evaluated the ability of nefiracetam to attenuate amnesia induced by dopaminergic agonism."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T16","span":{"begin":204,"end":224},"obj":"ChemicalEntity"},{"id":"T14","span":{"begin":160,"end":171},"obj":"ChemicalEntity"},{"id":"T12","span":{"begin":11,"end":22},"obj":"ChemicalEntity"},{"id":"T47990","span":{"begin":124,"end":130},"obj":"GeneOrGeneProduct"},{"id":"T53027","span":{"begin":185,"end":192},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A16","pred":"ID:","subj":"T16","obj":"ChemicalEntity"},{"id":"A15","pred":"ID:","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_135004"},{"id":"A14","pred":"ID:","subj":"T14","obj":"C058876"},{"id":"A13","pred":"ID:","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_48538"},{"id":"A12","pred":"ID:","subj":"T12","obj":"D001058"},{"id":"A1214","pred":"#label","subj":"T53027","obj":"D000647"}],"text":"Given that apomorphine inhibits passive avoidance retention when given during training or in a defined 10-12h post-training period, we evaluated the ability of nefiracetam to attenuate amnesia induced by dopaminergic agonism."}